1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters by Session

Thumbnail for Validation of Baseline Total Metabolic Tumor Volume (TMTV) and Total Lesion Glycolysis (TLG) as Predictors of Early Progression (POD24) in Follicular Lymphoma: A Retrospective Study of 100 Patients in Brazil

IBCL - 1459

Validation of Baseline Total Metabolic Tumor Volume (TMTV) and Total Lesion Glycolysis (TLG) as Predictors of Early Progression (POD24) in Follicular Lymphoma: A Retrospective Study of 100 Patients in Brazil

Andre Meireles

Poster Presenter: Andre Meireles

$Thumbnail for Clinically Relevant Subgroup Analysis From the Randomized Phase 3 EPCORE FL-1 Trial: Treatment (Tx) Effect of Epcoritamab (E) With Lenalidomide and Rituximab (R2) in Relapsed/Refractory Follicular Lymphoma (R/R FL)$

IBCL - 1506

Clinically Relevant Subgroup Analysis From the Randomized Phase 3 EPCORE FL-1 Trial: Treatment (Tx) Effect of Epcoritamab (E) With Lenalidomide and Rituximab (R2) in Relapsed/Refractory Follicular Lymphoma (R/R FL)

Bradley Hunter

Poster Presenter: Bradley Hunter

SOHO 2026 Annual Meeting

Posters by Session

Validation of Baseline Total Metabolic Tumor Volume (TMTV) and Total Lesion Glycolysis (TLG) as Predictors of Early Progression (POD24) in Follicular Lymphoma: A Retrospective Study of 100 Patients in Brazil

Clinically Relevant Subgroup Analysis From the Randomized Phase 3 EPCORE FL-1 Trial: Treatment (Tx) Effect of Epcoritamab (E) With Lenalidomide and Rituximab (R2) in Relapsed/Refractory Follicular Lymphoma (R/R FL)

Efficacy of BRAF Inhibitors Plus Rituximab in Relapsed or Refractory Hairy Cell Leukemia: A Systematic Review and Meta-Analysis

Sociodemographic Factors and Treatment Patterns Associated With Overall Survival in Splenic Marginal Zone Lymphoma: A Nationwide Retrospective Cohort Study (2000-2022)

Concomitant Proton Pump Inhibitors Do Not Worsen Immune Checkpoint Inhibitor Outcomes Despite a Prognostically Unfavorable Baseline BMI Imbalance: A Real-World Confounder Analysis

Clinicodemographic Predictors of Outcome in Lymphoplasmacytic Lymphoma: Insights From a SEERStat Multivariate Model

Life Expectancy of Hairy Cell Leukemia Patients Approaches General Population: An Updated Analysis of 5669 Cases from SEER Database (1978-2020)

Real-World Outcomes of Bendamustine & Rituximab With or Without Maintenance Rituximab in Follicular Lymphoma: A TriNetX Analysis

Noncancer Competing Mortality in Follicular Lymphoma: Cardiovascular, Infectious, and Second Malignancy Deaths in a Population-Based Cohort, SEER 2000-2022